Previous close | 200.37 |
Open | 200.53 |
Bid | 200.79 x 900 |
Ask | 200.99 x 800 |
Day's range | 198.65 - 201.73 |
52-week range | 160.21 - 236.90 |
Volume | |
Avg. volume | 970,667 |
Market cap | 32.328B |
Beta (5Y monthly) | 0.73 |
PE ratio (TTM) | 62.04 |
EPS (TTM) | 3.23 |
Earnings date | 29 May 2024 - 03 June 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 241.47 |
Veeva Systems (NYSE: VEEV) today announced Veeva Vault CRM Campaign Manager, a new industry-specific marketing application that simplifies and speeds non-personal promotion to healthcare professionals. Vault CRM Campaign Manager lives in the same Vault as Veeva Vault CRM and shares the same customer data, giving sales and marketing the effortless synchronization needed for true customer centricity. Through orchestrated campaigns, marketing users in Vault CRM work side by side with field CRM user
Veeva Systems (NYSE: VEEV) today announced that leaders from Bayer, Genentech, Novo Nordisk, Takeda, and others will be among the keynote speakers at the 2024 Veeva Commercial Summit, May 7-8 in Boston. Commercial and medical affairs professionals will share how they are innovating across content, data and analytics, and customer interactions to advance the future of customer-centric engagement.
3D Systems (DDD) receives 510(k) clearance for its innovative 3D-printed, patient-specific cranial implant solution, the VSP PEEK Cranial Implant, from the FDA.